Top 10 peptides for 2026

The GLP-1 receptor agonist that moved this entire class into the mainstream. Still the compound most people mean when they say “peptide” in 2026.

A dual GIP/GLP-1 receptor agonist — the second wave of the metabolic class, and the year's most-discussed alternative to semaglutide.

A triple agonist (GLP-1, GIP, and glucagon receptors) still moving through clinical research — the compound generating the most forward-looking chatter.

A synthetic pentadecapeptide derived from a protective protein found in gastric juice, studied in research on tissue repair. The perennial number one in recovery circles.

A synthetic fragment of thymosin beta-4, studied in research on cell migration and repair. Frequently discussed alongside BPC-157.

A selective growth-hormone secretagogue, widely referenced in research on GH pulse stimulation and often paired in discussion with CJC-1295.

A modified GHRH analog studied for its short-acting release profile — the other half of the most talked-about GH pairing.

A naturally occurring copper-binding tripeptide, studied extensively in skin and cosmetic research. The crossover compound between peptide and skincare communities.

A mitochondrial-derived peptide studied in research on cellular energy metabolism — a favorite topic in the longevity conversation.

Not a peptide, strictly — a coenzyme central to cellular metabolism that shows up in nearly every longevity protocol discussion, so it earns its slot.